Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:temazepam
|
| gptkbp:approvedBy |
gptkb:FDA
1981 |
| gptkbp:ATCCode |
N05CD07
|
| gptkbp:availableOn |
capsule
|
| gptkbp:broadcastOn |
Schedule IV (US)
|
| gptkbp:cause |
dependence
withdrawal symptoms |
| gptkbp:contraindication |
pregnancy
history of substance abuse |
| gptkbp:drugClass |
benzodiazepine
|
| gptkbp:eliminationHalfLife |
8-20 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Restoril
|
| gptkbp:interactsWith |
gptkb:beer
opioids other CNS depressants |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Mallinckrodt_Pharmaceuticals
|
| gptkbp:metabolism |
liver
|
| gptkbp:overdoseSymptoms |
confusion
coma respiratory depression |
| gptkbp:pregnancyCategory |
gptkb:X_(US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
fatigue headache drowsiness |
| gptkbp:usedFor |
insomnia
|
| gptkbp:bfsParent |
gptkb:Temazepam
gptkb:temazepam |
| gptkbp:bfsLayer |
7
|